1.
Li X, He J, Song C. Research Progress on the CDK4/6 Signaling Pathway and Clinical Application of Its Inhibitors in HR+/HER2- Breast Cancer. Health Nexus [Internet]. 2025 Nov. 15 [cited 2026 Sep. 18];1:31-7. Available from: https://journals.panorama-sg.com/HealthNexus/article/view/148